February 25: Alberta RNA Research and Training Institute (ARRTI) & UNSW RNA Institute

Value of the Information & Strength of the Argument

The value of the information is high, as it presents novel methods and ongoing research in RNA biology and therapeutics. The first talk provides a detailed and well-argued case for using AUC to characterize LNPs, addressing a critical need in the field. The second talk offers a systematic approach to designing CRISPR antivirals, with clear rationale and preliminary data. The third talk synthesizes existing literature to propose a regulatory role for lncRNAs in behavior, though it is more speculative. The argumentation is generally solid, with each speaker providing evidence and logical reasoning. However, the second talk is still in early stages, and the third talk lacks experimental data from the presenter.

Scientific Rigor, Source Quality, Title Accuracy

The scientific rigor is high, with detailed methodologies and data presented. The first talk is based on a recent publication, and the second talk uses established bioinformatics tools and standard cloning techniques. The third talk cites numerous studies, though specific references are not provided in the description. The title accurately reflects the content, as it is a seminar series with three distinct presentations. The lack of explicit citations in the description is a minor weakness, but the presentations themselves appear well-referenced.

The title accurately reflects the content, as it describes the collaborative seminar series with three presentations from ARRTI and UNSW RNA Institute.

8/10

The seminar presents original research from three speakers, with detailed methodology and data. The first talk on LNP characterization by AUC is based on a recent publication and includes rigorous experimental validation. The second talk on CRISPR-Cas13d antivirals is a PhD project with clear objectives and preliminary data. The third talk on lncRNA and behavior is a review of existing literature, presented by an expert. Overall, the content is scientifically sound, but the lack of peer-reviewed references in the description and the preliminary nature of some data slightly reduce the score.

Markers derived by PSI from the transcript: the creator did not define chapters.

• 02:00Introduction to the seminar series and first speaker Sophia Bird.
• 05:00Sophia Bird explains the challenges in LNP characterization and introduces AUC.
• 10:00Sophia Bird presents sedimentation velocity data and density matching results.
• 15:00Sophia Bird concludes and answers questions about LNP heterogeneity.
• 20:00Michael D'Souza introduces alphaviruses and the need for antiviral therapeutics.
• 30:00Michael D'Souza details the design of CRISPR-Cas13d guide RNAs targeting VEEV RdRp.
• 40:00Michael D'Souza discusses plasmid construction and future validation steps.
• 50:00Kelly Clemens presents on long non-coding RNAs as regulators of behavior.
• 55:00Kelly Clemens concludes and the seminar wraps up.

• Characterization of mRNA Loaded LNPs by Analytical Ultracentrifugation — Sophia Bird's presentation is based on a recent publication from her lab, but no specific URL is provided.
• CAS13Design web service — Michael D'Souza mentions using CAS13Design for guide RNA design, but no URL is given.
• Bowtie alignment tool — Michael D'Souza mentions using Bowtie for off-target analysis, but no URL is given.

• Analytical ultracentrifugation for characterization of nanoparticles — This article supports the use of AUC for nanoparticle characterization, aligning with Sophia Bird's talk.
• CRISPR-Cas13 as a tool for RNA targeting — This paper discusses the potential of Cas13 for RNA targeting, supporting Michael D'Souza's approach.

• Limitations of DLS for nanoparticle sizing